Differential expression of microRNA, miR-150 and enhancer of zeste homolog 2 (EZH2) in peripheral blood cells as early prognostic markers of severe forms of dengue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Differential expression of microRNA, miR-150 and enhancer of zeste homolog 2 (EZH2) in peripheral blood cells as early prognostic markers of severe forms of dengue ; volume:27 ; number:1 ; day:18 ; month:1 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of biomedical science ; 27, Heft 1 (18.1.2020), 1-9, 12.2020
- Urheber
-
Hapugaswatta, Harsha
Amarasena, Pubudu
Premaratna, Ranjan
Seneviratne, Kapila N.
Jayathilaka, Nimanthi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-020-0620-z
- URN
-
urn:nbn:de:101:1-2020042104333430773387
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hapugaswatta, Harsha
- Amarasena, Pubudu
- Premaratna, Ranjan
- Seneviratne, Kapila N.
- Jayathilaka, Nimanthi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Enhancer of polycomb homolog 1 in regulation of cancer progression relevant gene signatures
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
Prävalenz und prognostische Bedeutung der „Enhancer of Zeste Homolog 2“ Expression beim Nierenzellkarzinom
Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
Calcineurin/NFATc3 pathway mediates myocardial fibrosis in diabetes by impairing enhancer of zeste homolog 2 of cardiac fibroblasts
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Enhancer of polycomb homolog 1 in regulation of cancer progression relevant gene signatures
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
Prävalenz und prognostische Bedeutung der „Enhancer of Zeste Homolog 2“ Expression beim Nierenzellkarzinom
Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
Calcineurin/NFATc3 pathway mediates myocardial fibrosis in diabetes by impairing enhancer of zeste homolog 2 of cardiac fibroblasts
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Enhancer of polycomb homolog 1 in regulation of cancer progression relevant gene signatures
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
Prävalenz und prognostische Bedeutung der „Enhancer of Zeste Homolog 2“ Expression beim Nierenzellkarzinom
Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)